India’s drug regulator has uncovered serious lapses in pharmaceutical testing after dozens of children died from toxic cough syrup triggering industry-wide scrutiny and regulatory crackdowns.
Glimpse:
Seventeen children under age 5 have died in India, allegedly from ingesting cough syrups tainted with diethylene glycol (DEG). Regulatory audits revealed that multiple pharmaceutical firms failed to properly test raw materials and finished products. Some plants have been shut down, investigations have been launched, and stricter oversight is being demanded.
In a shocking health scandal, India’s central drug regulator has flagged systematic testing failures at pharmaceutical production units following the deaths of multiple young children. The cough syrup implicated in these fatalities had DEG contamination almost 500 times above permissible limits.
Factory inspections uncovered that many firms ignored mandated quality control protocols, failing to test raw inputs or carry out final product analyses. Two Gujarat-based firms, Shape Pharma and Rednex Pharmaceuticals, were specifically spotlighted for substandard practices. As a result, their manufacturing operations are now under suspension.
Several states, including Telangana, have issued advisories to halt use of syrups produced by these firms. The government has launched criminal investigations, issued show-cause notices, and initiated license cancellations. Observers warn of reputational damage to India’s pharmaceutical export sector if such lapses continue unchecked.
“A single laboratory failure can cost lives. In a sector where trust is the currency, negligence is the deadliest currency crash.”
By
HB Team
